A prospective-retrospective observational registry of patients diagnosed with chronic heart failure in the regions of the Russian Federation. The study is non-interventional and does not involve any interventions in clinical practice, the choice of treatment methods (including the type of medical device used and the method of surgical intervention) and examination. A control observation group is not intended.
The study will include retrospective and prospective data of patients with an outpatient or inpatient diagnosis of CHF. The duration of the observation period of an individual patient with CHF is limited by the study period, or the patient's death, and includes the studied retrospective and dynamic prospective parameters. Prospective data of CHF (any stage and FC) subjects are planned to be included sequentially as they appear in inpatient CHF centers and outpatient CHF offices until 12/31/2027 inclusive and further upon extension of the study. Retrospective data will be provided by chief freelance cardiologists of 33 constituent entities of the Russian Federation (Central Federal District, Ural Federal District, Siberian Federal District, Far Eastern Federal District) (individually, according to agreement)
Study Type
OBSERVATIONAL
Enrollment
20,000
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Organization
Moscow, Russia
RECRUITINGAge of subjects with different phenotypes and stages of CHF
Time frame: Every 12 months, up to 3 years
Female to male sex ratio of subjects with different phenotypes and stages of CHF
Time frame: Every 12 months, up to 3 years
Clinical status of subjects with different phenotypes and stages of CHF
Time frame: Every 12 months, up to 3 years
Proportion of employable and working subjects with different phenotypes and stages of CHF
Time frame: Every 12 months, up to 3 years
The proportion of subjects with different algorithms for diagnosing CHF and the proportion of subjects with a verified diagnosis of CHF (established according to the recommended algorithm for diagnosing CHF)
Time frame: Every 12 months, up to 3 years
The proportion of subjects taking drugs of each class and all four classes of the recommended four-component therapy regimen (in the overall choice and in different phenotypes of CHF; working/non-working age; working/non-working)
Time frame: Every 12 months, up to 3 years
Number and proportion of subjects with wearable devices when using an online tool for identifying subjects with CHF with indications for high-tech medical care
Time frame: Every 12 months, up to 3 years
Number and proportion of subjects when using an online tool for identifying subjects with CHF with indications for high-tech medical care
Time frame: Every 12 months, up to 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Proportions of subjects with an increase in EF ≥10% and a decrease in the functional class of CHF by 1 point
Time frame: Every 12 months, up to 3 years
The proportion of subjects hospitalized for decompensated CHF in the departments of therapeutic and cardiology profiles *
Time frame: Every 12 months, up to 3 years
Proportion of subjects with newly diagnosed type 2 diabetes*
Time frame: Every 12 months
Proportion of subjects with deterioration of renal function*
Time frame: Every 12 months, up to 3 years
Proportion of subjects with newly diagnosed malignant neoplasm*
Time frame: Every 12 months, up to 3 years
Proportion of subjects who died from CV causes*
Time frame: Every 12 months, up to 3 years
Proportion of subjects with different causes of death*
Time frame: Every 12 months, up to 3 years
Incidence and event rates (per 100 subject-years) for hospitalizations due to HF*
Time frame: Every 12 months, up to 3 years
Incidence and event rates (per 100 subject-years) for death from CV causes*
Time frame: Every 12 months, up to 3 years
Incidence and event rates (per 100 subject-years) for death from any cause*
Time frame: Every 12 months, up to 3 years
The proportion of subjects with preferential drug provision for cardiovascular disease, diabetes mellitus*
Time frame: Every 12 months, up to 3 years
Average frequency of outpatient visits of subjects with CHF to medical institutions*
Time frame: Every 12 months, up to 3 years
The proportion of subjects registered with a cardiologist or therapist with different phenotypes and stages of CHF*
Time frame: Every 12 months, up to 3 years
Average frequency of telephone patronage *
\*- in the overall sample and in groups of subjects with HFrEF, HFmrEF, HFpEF and in different age categories (18-49 years; 50-64 years; 65-74 years; 75-85 years;\>85 years); of working/non-working age; employed/non-employed
Time frame: Every 12 months, up to 3 years